chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Flu like symptoms; extreme muscle tightness that she was not able to get up or move on her own; Bedridden for 4 to 5 days; 2nd shot is not intended to; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE TIGHTNESS (extreme muscle tightness that she was not able to get up or move on her own), BEDRIDDEN (Bedridden for 4 to 5 days) and INTENTIONAL PRODUCT USE ISSUE (2nd shot is not intended to) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In February 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE TIGHTNESS (extreme muscle tightness that she was not able to get up or move on her own), BEDRIDDEN (Bedridden for 4 to 5 days) and INTENTIONAL PRODUCT USE ISSUE (2nd shot is not intended to). The patient was treated with Hospice care (in the emergency doctor treated her) for Influenza like illness and Hospice care (in the emergency doctor treated her) for Muscle tightness. At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), MUSCLE TIGHTNESS (extreme muscle tightness that she was not able to get up or move on her own) and BEDRIDDEN (Bedridden for 4 to 5 days) was resolving and INTENTIONAL PRODUCT USE ISSUE (2nd shot is not intended to) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication of the patient was not reported. No treatment information was provided by the reporter for the events BEDRIDDEN and INTENTIONAL PRODUCT USE ISSUE.  Next day after taken to the emergency, the patient was sent home. The patient did not take the 2nd shot and was not intended to.   Most recent FOLLOW-UP information incorporated above includes: On 12-Jul-2021: Follow-up received on 12-Jul-2021, events were added, patient demographics was updated.
About 30 minutes later my arm was itchy, then swollen and I felt slightly short of breath so I took 50mg of Benadryl and my symptoms went away. When I woke up today, they were back so I took another 50 mg of Benadryl. Now at 7:30 pm I am more short of breath and wheezing, and coughing so I am more concerned. I am a nurse, so I know when I would need to go to the hospital. I will take more Benadryl but I thought I should report this.
He got the vaccine, no reaction to the vaccine injection site.  On coming into work this morning he feels like he is having a manic episode from his depression.  Arthritis is feeling better after the injection.  His manic episode consists of being overly active.   He has notified his doctor and they told him to call the pharmacy which gave him our number.   About 5 years ago he had a hyperactive thyroid disorder and is in remission from that.
Received Expired Dose; This spontaneous case was reported by a physician and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired Dose). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Received Expired Dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication reported. No treatment information was provided.   This case was linked to MOD-2021-421914 (Patient Link).
From initial information received from a health care professional, regarding an adverse event occurring in the USA, it was reported that a 5 year old female patient received Daptacel vaccination, lot number C1698AA, administered intra muscularly in the right thigh on 08/11/2004. Some time after the vaccination, onset date illegible on source document, it was reported that the patient developed a swollen, red, indurated area over her right anterior thigh that was warm to the touch. The patient was placed on antibiotics for Cellulitis with allergic reaction to DTaP. Reportedly the patient also developed a temperature. Reportedly the patient recovered from this experience. From additional information received on 10/11/2004 from a health care professional,  the patients full name,address and telephone number were provided. Reportedly the patient received her fourth dose of IPOL, lot number 409030, administered intramuscularly in the left thigh as well as her second dose of MMR, lot number 0101N, manufactured by Merck, administered intramuscularly in the right thigh in addition to Daptacel on 08/11/2004. The patient experienced the above mentioned symptoms the next day, on 08/12/2004. Symptoms resolved with Keflex regimen on 08/16/2004. The reporter of this case is the same reporteer for cases 200402938, 200402947, 200402948, 2004002949, and 200402950. From additional information received on 11/12/2004 from the initial reporter, the IPOL lot number was confirmed as 904030, which is not an Aventis lot number. No further information is anticipitated, this case is considered closed.
Developed redness (swelling at site, few onsight red rash arm and head / neck and upper trunk - dry cough
pt recv vax 1APR97 & 15min later devel visual distortion;sx lasted 5min & then resolved;
Employee stated that after finishing work, she walked on the treadmill. While walking on treadmill, she began to feel weak and limbs felt heavy. Employee started feeling extremely fatigued while driving home from work. Once at home she felt some nausea, but no vomiting. Employee states she felt so fatigued, that she had to hold on to the door to get to bed, and went to bed with clothes and shoes on. This morning after the vaccine she had mild dizziness, and couldn't remember all her morning routines. Did drive to work cautiously this AM, and states she is feeling a little better, but still feels a little foggy. Has not completely recovered (#20) but states she is feeling better. BP-127/61.
Felt as if I was getting the flu, no fever, rash over chest, back, neck (same rash I get when contracting a virus, I.e. common cold, etc).  Felt "under the weather" for about 12-24 hours.
One week after vaccine administration,  tachycardia, heart palpitations, and fluttering/pounding feeling in chest occurred intermittently for several minutes at a time throughout the day, even at rest. These symptoms were distinct from heart palpitations felt in the past, which lasted only seconds. Symptoms peaked about 8-9 days after vaccination.  During the 10-14 days after vaccination, symptoms slowly subsided until they occurred only during exercise or other events that would normally elevate heart rate. 15 days after vaccination, symptoms stopped and no fluttering was felt in chest even with exercise. The episodes caused hesitance about getting the second dose of the vaccine.
Chest pain, headache, having to clear congestion from throat, soreness and swelling at injection site, sharp pain on inner thigh, I fell out of my bed for the first time in my life at approximately 10pm on 10/30.
Redness heat, itching and swelling at injection site. Rash sped down arm to elbow. [treatment] Took Sudafed for two days-called pop  she told me to take cetirizine.
Cellulitis - warm, redness, swelling left posterior thigh Tx with 2 gram Rocephin IM injection and Clindamycin 75/5 15 ml TID x 10 days.
Patient called to report a rash "chicken pox like" on her whole body. Taking medication as per MD to treat the rash.
Within hours of receiving the vacine I began having vaginal bleeding spotting. By that evening it progressed to bleeding  as if my menstrual cycle began. This was unusual because I  just had my period. The last day of my previous cycle was 6 days earlier. This was accompanied by night swears and then a migrane that onset the following day along with usual symptoms of fatigue and a sore arm.
LEFT DELTOID AREA PRURITIS, MODE3RATE ERYTHEMA, INCREASED WARMTH, AND MILDLY TENDER 2 DAYS POST. RECEIVING DTaP, IM IN THE LEFT DELTOID.  NO INDURATION, NO FEVER. SEEN IN ER DIAGNOSED AS ALLERGIC REACTION VERSUS CELLULITIS, AND GIVEN BENADRYL AND ERYTHROMYCIN.  IMPROVED BY FOLLOWING DAY.
patient received the vaccine at 3:20 pm and was sitting in the observation waiting area for 7-8 minutes per pt when she started feeling like her tongue was swelling and her throat was tight, patient states she was jittery and felt like something was crawling up her legs. after assessment of the patient epinephrine and Benadryl were given both IM to pt and EMS was called and pt was transported, pt was stable at transport. EMS arrived at 3:42pm.
Hives all over, swollen tender penis.  Rash and swelling come and go as does the angioedema which has also occurred on lips, face, eyes.  As of 12/18 has not yet resolved.  Also with some myalgias.
Patient received a flu shot at the pharmacy,  but had already received a flu shot one month earlier at the doctor's office.
Little pain; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Little pain) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     Concurrent medical conditions included Varicose veins.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN (Little pain). At the time of the report, PAIN (Little pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  Treatment medications were not provided by the reporter.   This case was linked to MOD-2021-279410 (Patient Link).
5 hours after injection patient experienced numbness on right side of face as well as facial drooping. This lasted about 2 hours.  About 7 hours after injection patient experienced labored breathing, chills and body aches; these symptoms lasted for about 36 hours.
Patient stated she felt slight tenderness and warmth to injection site. Area is hard and slightly swollen. Gave her cold compress and made ibuprophen available to her. Clinic contacted and she was referred to urgent care. Clinic stated it was slightly irritated. Prescribed her BENADRYL, HYDROCORDISONE CREAM, and warm compress to area.
Metallic taste. Nausea. Light sensitivity. Vomiting. 72 hours post injection.
May not have received the full dose; A spontaneous report was received from a physician, concerning a patient of unspecified age and gender, who received Moderna's COVID-19 vaccine (mRNA-1273) and may not have received the full dose.    The patient's medical history was not provided. No relevant concomitant medications were reported.   On an unknown date, prior to the onset of event, the patient received their first of two planned doses of mRNA-1273 (lot number unknown) intramuscularly for prophylaxis of COVID-19 infection.   On an unknown date, the physician reported that someone may not have received the full dose.   Action taken with mRNA-1273 in response to the event was not reported.  The event may not have received the full dose was considered resolved on an unspecified date.; Reporter's Comments: This case concerns a patient of unknown age who received their first of two planned doses of mRNA-1273 (lot number unknown) intramuscularly for prophylaxis of COVID-19 infection and may not have received the full dose.  There were no reported adverse events after the vaccine administered in this case of incomplete dose administered.
About 2 minutes after injection patient reported redness showing on both hands and feeling a little bit dizziness. At the time she was on the W/C to ED, she reported her throat feeling tight.
Mom called back about 3-4 hours, post vax, stating pt was complaining of facial numbness and mild swelling. No rash or respiratory distress per mom's report. Advised to give pt Benadryl and see PMD if no relief or improvement in 30-40 minutes or go to ER if she has any respiratory distress. Called on 7/18/00 and pt stated Benadryl was effective and had no further problems.
ADULT OBSTRUCTIVE SLEEP APNEA, MODERATE ACUTE PERICARDITIS, UNSPECIFIED
Adverse Event: Bell's Palsy on left hand side ~48H after 2nd dose of vaccine Treatment: Prednisone and Valacyclovir  Description: I received the second dose of the Moderna vaccine on Wednesday morning. I did not feel any side effects until later that night which included chills and body aches. However, throughout that evening and Thursday I had twitching of my eyes.   On the morning of Friday, 3/12 at around 9am (~48H after 2nd dose), I noticed it was weird to move my lips and remember that drinking coffee from the straw felt weird. It wasn't until 2:30pm when my husband and I were eating lunch that my husband noticed a drooping of the left side of my face.   We went to Emergency Department at 5:30pm and were seen by doctor who confirmed that it was Bell's Palsy on the left side of the face, the same side as the injection site.
This spontaneous report was received from a pharmacist concerning a 75 year old female patient with allergy to penicillin. The patient did not have medical history or concomitant medication. On 26-FEB-2017, the patient was vaccinated with PNEUMOVAX 23 (lot number M037669, expiration date 09-MAY-2018, dose, route and anatomical injection site were not reported) for pneumonia prevention. On 26-FEB-2017 at night, the patient experienced "pain and redness" in the left arm. On 27-FEB-2017, the patient's doctor diagnosed her with cellulitis and prescribed KEFLEX. A product quality complaint was not involved. At the time of the report, the outcome of cellulitis was not recovered. The causal relationship between the event and PNEUMOVAX 23 was not reported. Upon internal review cellulitis was considered to be as medically significant. Additional information has been requested.
pt had angioedema with significant lip swelling within 24 hours of receiving first dose.
Woke the day after injection with muscle weakness and soreness to all extremities, hands swollen and decreased grip strength. Was assessed at an Urgent Care 10/25 and saw primary care MD 10/26. Ibuprofen recommended for symptom relief.
This spontaneous report as received from a other health professional refers to unspecified number of patients (approximately less than 10 patients) of unknown age. No current condition or medical history was reported. On unknown dates the patients were vaccinated with GARDASIL intramuscular injection (dose, route and lot number not reported). No concomitant therapy was reported. On unknown dates, the patients received improperly stored GARDASIL. No adverse symptoms were reported. The temperature excursion for the GARDASIL was supported with in-house stability data. There was no product quality complaint involved. The outcome of the events was not reported. Action taken with the suspect product and the causality was not provided. Additional information has been requested.
Information has been received form a consumer with high blood pressure, blood protein-MGUS, and a mold allergy with post nasal drip and a past medical history of hysterectomy who was vaccinated with a dose of pneumococcal vaccine 23 polyvalent. Concomitant therapy included levothyroxine sodium (SYNTHROID). The patient had an allergic reaction, a red rash, after receiving the vaccine. The patient did not seek medical attention. Additional information has been requested.
Right side of face tingly, slightly numb.  Tingly feeling was gone the next day.  Slightly numb feeling lasted at least three or four days.  Right arm was sore for four days.  Until 12/28, pain in upper right arm would start for no reason, usually in the evening.
This case is one of a cluster of three patients who experienced adverse events following administration of ADACEL (lot number U4090BA and sanofi pasteur Ltd. lot number C3961) and FLUZONE, lot number UH463AA. The events for the other patients were captured in case 2011-10183 and 2011-10184. Initial report was received on 14 October 2011 from a healthcare provider. A 59-year-old female patient (date of birth not reported) had received on 04 October 2011 and intramuscular injection of FLUZONE and ADACEL (site of administration not reported). On 12 October 2011, the patient experienced decreased range of motion and pain down her arm. The patient was prescribed ice, heat compresses, ibuprofen and TYLENOL. No further informational was available at the time of the report. The patient's outcome was reported as resolving. Documents held by sender: none.
Rash, Fever, Golf ball size lump on left arm. 8 days after vaccine was given.
flu like symptoms; Developed COVID-19; A spontaneous report was received from a consumer concerning her friend a female patient of unknown age who received Moderna's COVID-19 vaccine (mRNA-1273) and developed Covid-19 and flu like symptoms.  The patient's medical history was not provided. No concomitant medications were reported.  On an unknown date, the patient received their first of two planned doses of mRNA-1273 (Lot# unknown, Exp. unknown).   On an unknown date, the patient developed Covid-19 and flu like symptoms. No treatment information was reported.  The Action taken with mRNA-1273 in response to the events was unknown.  The outcome for the events, Covid-19 and flu like symptoms was unknown.  The reporter did not provide an assessment for the events.; Reporter's Comments: This case concerns a female of unknown age who developed Covid-19 and flu like symptoms on an unknown date and in addition, patient received vaccine on unknown date. Very limited information regarding these events has been provided at this time.  Further information has been requested.
patient who is 17 years old, received the vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who is 17 years old, received the vaccine) in a 17-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who is 17 years old, received the vaccine). On 04-Feb-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (patient who is 17 years old, received the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 31-Mar-2021: NNI
3RD DOSE MODERNA COVID VACCINE GIVEN 3/22/22, #046L21A; 4TH DOSE MODERNA COVID VACCINE GIVEN 7/21/22, #051B22A; Pt resides in SNF; pt had a positive COVID test 8/23/22 in the SNF; no treatments in medical records received; pt passed away in the SNF
Patient received the SHINGRIX vaccine on 3/28/2018. On 3/29 patient began feeling flu like symptoms (headache, muscle pain, fever, upset stomach and nausea). Symptoms resolved on 3/30.
first dosage of HEPA on 01-FEB-2012, second dosage of HEPA on 01-APR-2014; This spontaneous report has been received from a physician, via medical records (immunization record) from a case in litigation for HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast) (GARDASIL 9) (MARRS # 2303USA000135), concerning a 11-year-old male patient (pt). Concomitant vaccinations included diphtheria vaccine toxoid (+) pertussis vaccine acellular 5-component (+) tetanus vaccine toxoid (ADACEL) and meningococcal MCV40 (CVX 136). Information about concurrent condition and medical history was not reported.   On 01-FEB-2012 and 01-APR-2014, the pt was vaccinated with 2 doses of hepatitis a vaccine, inactivated (manufacturer unknown) (reported as hepatitis A vaccine PED/ADOL) (strength, exact dose, route,  lot # and expiration date were not provided) for prophylaxis, respectively (inappropriate schedule of product administration).   This is one of several reports for the same pt.; Sender's Comments:  US-009507513-2306USA008273: US-009507513-2303USA000135:
This spontaneous report was received from a nurse refers to a patient of unknown age and gender. The patient's pertinent medical history, allergic reactions and concomitant medications were unspecified. On an unknown date, the patient was vaccinated with improperly stored PEDVAXHIB (lot # M001814, expiry date 15-OCT-2018, dose, strength, dose number, vaccination site, route not provided). No adverse effects were reported. Product quality complain (PQC) was not involved. No further information was provided. This is one of several reports received from the same reporter. Additional information has been requested.
This case was reported by a consumer via call center representative and described the occurrence of sickness in a female patient who received Flu unspecified (Flu vaccine) for prophylaxis. Co-suspect products included Hepatitis A vaccine for prophylaxis and Hepatitis B vaccine for prophylaxis. On an unknown date, the patient received Flu vaccine at an unknown dose, Hepatitis A vaccine at an unknown dose and Hepatitis B vaccine at an unknown dose. On an unknown date, unknown after receiving Flu vaccine and Hepatitis A vaccine and an unknown time after receiving Hepatitis B vaccine, the patient experienced sickness and headache. On an unknown date, the outcome of the sickness and headache were unknown. It was unknown if the reporter considered the sickness and headache to be related to Flu vaccine, Hepatitis A vaccine and Hepatitis B vaccine. Additional information received as follows: The age at vaccination was not reported. The reporter said that she had a small frame and did not weight much. However, she always end up having the same dosing of vaccine as everyone else and had a miserable time with them. The patient reacted terribly to the vaccine. She felt sick and got a headache. That has happened with her flu vaccines, hepatitis vaccines. The patient did not want to provide any details on herself or the vaccines. This has been linked to the case US20181792010, reported by the same reporter.
This case was reported by a healthcare professional via sales representative and described the occurrence of pain in an unspecified number of subjects of unspecified ages and gender who were vaccinated with BOOSTRIX (GlaxoSmithKline). On an unspecified date the subjects received unspecified dose of BOOSTRIX (unknown). At an unspecified time after vaccination with BOOSTRIX, the subjects experienced pain. The healthcare professional stated the office recently switched from ADACEL to BOOSTRIX and reported that BOOSTRIX seems to hurt more than ADACEL. At the time of the report no additional information on how may subject reported pain after BOOSTRIX was available. At the time of reporting the outcome of the pain was unspecified.